Who owns ASTRIA THERAPEUTICS INC?
- Ticker: ATXS
- CUSIP Number: 04635x102
Tip: Access positions for across all investors
Analyze quarterly positions in Astria Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Astria Therapeutics stock
Who bought or sold ASTRIA THERAPEUTICS INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Perceptive Advisors | 4.0M | $31M | 83% | Dec 2023 |
|
| Fairmount Funds Management | 3.6M | $27M | 87% | Dec 2023 |
|
| VR Adviser | 3.2M | $25M | 100% | Dec 2023 |
|
| Vivo Capital | 2.5M | $19M | 48% | Dec 2023 |
|
| Vanguard Group | 2.1M | $16M | 36% | Dec 2023 |
|
| Sphera Funds Management | 1.2M | $8.8M | 98% | Dec 2023 |
|
| Rosalind Advisors | 1.1M | $8.7M | 100% | Dec 2023 |
|
| Logos Global Management | 545k | $4.2M | 0% | Dec 2023 |
|
| Tri Locum Partners | 543k | $4.2M | -9% | Dec 2023 |
|
| DAFNA Capital Management | 449k | $3.4M | 52% | Dec 2023 |
|
| Ikarian Capital | 375k | $2.9M | 0% | Dec 2023 |
|
| Millennium Management | 220k | $1.7M | 100% | Dec 2023 |
|
| ADAR1 Capital Management | 191k | $1.5M | 100% | Dec 2023 |
|
| Citadel Advisors | 165k | $1.3M | 436% | Dec 2023 |
|
| Jacobs Levy Equity Management | 153k | $1.2M | -6% | Dec 2023 |
|
| Bank of New York Mellon | 92k | $709k | 32% | Dec 2023 |
|
| Charles Schwab Investment Management | 87k | $667k | 27% | Dec 2023 |
|
| Bank of America Corporation | 55k | $422k | 64% | Dec 2023 |
|
| Trexquant Investment | 53k | $409k | 100% | Dec 2023 |
|
| Barclays | 49k | $379k | 487% | Dec 2023 |
|
| Jane Street | 40k | $308k | 100% | Dec 2023 |
|
| Rhumbline Advisers | 38k | $289k | 18% | Dec 2023 |
|
| UBS Group | 36k | $278k | 180% | Dec 2023 |
|
| Schonfeld Strategic Advisors | 36k | $277k | -24% | Dec 2023 |
|
| Two Sigma Investments | 34k | $262k | 100% | Dec 2023 |
|
| Wells Fargo & Company | 27k | $206k | 395% | Dec 2023 |
|
| Jpmorgan Chase & Co | 22k | $168k | 26% | Dec 2023 |
|
| Alyeska Investment Group | 21k | $160k | 100% | Dec 2023 |
|
| Deutsche Bank Aktiengesellschaft | 17k | $128k | 0% | Dec 2023 |
|
| American International | 16k | $126k | 29% | Dec 2023 |
|
| Goldman Sachs Group | 16k | $126k | -43% | Dec 2023 |
|
| Simplex Trading | 16k | $120k | 1372% | Dec 2023 |
|
| PanAgora Asset Management | 16k | $119k | 100% | Dec 2023 |
|
| Marshall Wace | 14k | $110k | 100% | Dec 2023 |
|
| MetLife Investment Advisors | 14k | $104k | 0% | Dec 2023 |
|
| Mirae Asset Global Investments | 14k | $104k | 0% | Dec 2023 |
|
| Connor, Clark & Lunn Investment Management | 14k | $104k | -68% | Dec 2023 |
|
| Royal Bank of Canada | 13k | $96k | 245% | Dec 2023 |
|
| New York State Common Retirement Fund | 10k | $79k | 0% | Dec 2023 |
|
| AJOVista | 6.6k | $51k | 100% | Dec 2023 |
|
| Citigroup | 4.7k | $38k | 36362% | Dec 2023 |
|
| Legal & General Group | 3.5k | $27k | 34% | Dec 2023 |
|
| Amalgamated Bank | 3.4k | $26k | -7% | Dec 2023 |
|
| Summit Investment Advisors | 2.1k | $16k | 0% | Dec 2023 |
|
| Metropolitan Life Insurance Company | 2.0k | $15k | 41% | Dec 2023 |
|
| Advisor Group Holdings | 562.00 | $4.3k | 0% | Dec 2023 |
|
| GAMMA Investing | 457.00 | $6.4k | 6% | Mar 2024 |
|
| Red Tortoise | 298.00 | $2.3k | 100% | Dec 2023 |
|
| Key FInancial | 66.00 | $506.998800 | 0% | Dec 2023 |
|
| CWM | 48.00 | $999.998400 | 0% | Mar 2024 |
|
| Advisory Services Network | 41.00 | $314.998900 | 100% | Dec 2023 |
|
| Fortitude Family Office | 4.00 | $56.000000 | 0% | Mar 2024 |
|
Who sold out of Astria Therapeutics?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Polar Securities | Sep 2023 | 154k | $1.2M |
| Weiss Multi-strategy Advisers | Dec 2023 | 80k | $614k |
| Walleye Trading Advisors | Sep 2023 | 20k | $146k |
| Jump Financial | Sep 2023 | 15k | $111k |
| AQR Capital Management | Sep 2023 | 13k | $95k |